Posts Tagged ‘health equity’
February 3, 2025 — A new study in JAMA Network Open makes one thing very clear. Most people who take GLP-1 medicines for obesity quit within a year. Most who take them for diabetes are less likely to quit. Why are the disparities in GLP-1 medicines for obesity so great in comparison to their use for diabetes? It’s all […]
January 9, 2025 — The docket is open for you to lend your support until January 27. The Center for Medicare and Medicaid Services (CMS) is proposing to open up access to obesity medicines in both of the programs they oversee. This is something that we – with virtually every advocate for obesity care – have been seeking for […]
December 11, 2024 — The 2025 Dietary Guidelines Committee released its report yesterday and the reaction to this seems to be a bit of a yawn. “More beans and less red meat” was the headline from the Associated Press. “Highly conservative (not in a good sense)” is the bottom line from Marion Nestle, Emerita Professor of Nutrition, Food Studies, […]
December 6, 2024 — The market for precision nutrition advice is more than six billion dollars today and estimated to double by the end of this decade. Sales of continuous glucose monitoring devices are on their way to $20 billion within three years. But a new study this week in the American Journal of Clinical Nutrition suggests that the […]
November 7, 2024 — We have a lot to think about. Well over 3,000 people spent the better part of the week absorbing new science and insights into obesity – not to mention a momentous election. So as everyone sets about the task of catching up with routines, here is a quick take on five thoughts about what we’re […]
November 4, 2024 — From the Presidential Plenary at ObesityWeek, a primary issue standing in the way of progress is quite clear. Are we tipping toward equity in obesity care, or are we tripping over it? Tipping Toward Progress The argument for progress comes from putting the lived experience of obesity on stage to dominate the opening plenary for […]
October 30, 2024 — November is upon us and thus, so is ObesityWeek 2024 in San Antonio. This has been a year of radical change in the environment for obesity research, prevention, and care. So as we peruse the program for this meeting, it comes across as a year for consolidating the understanding of this disease and transformative options […]
October 6, 2024 — Change is in the air at this year’s FNCE – the annual Food and Nutrition Conference and Expo of the Academy of Nutrition and Dietetics. This is the world’s largest meeting of food and nutrition experts, registered dietitians, and nutritionists. But this year, we are seeing a subtle shift in the agenda at FNCE: less […]
September 23, 2024 — FDA is working hard to push drug companies to get more diversity into the clinical trials that are the foundation for bringing new, safe, and effective drugs into the market. In June, the agency issued guidance for diversity action plans to improve the representation of marginalized populations. But unfortunately, it has nothing to say about […]
September 7, 2024 — Recently, Novo Nordisk CEO Lars Fruergaard Jørgensen did a rare interview with NBC News to talk about the high price of obesity medicines that are proving to be so important for so many people. It seemed like a dress rehearsal for his coming appearance at a Senate hearing on the subject. He brought up the […]